| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |